A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma

Clinical trial NCT01156584 · COMPLETED

Trial details

NCT number: NCT01156584
Sponsor: Tocagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma

Start date: 2010-07-01
Primary completion: 2016-08-18
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.